Patent details

Basic Information

Publication number:

EP3419650

PCT Application Number:

US2017019502

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177573755

PCT Publication Number:

WO2017147522

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

French Title of Invention:

FORMULATIONS LYOPHILISÉES POUR ANTIDOTE ANTI-FACTEUR XA

German Title of Invention:

LYOPHILISIERTE FORMULIERUNGEN FÜR FAKTOR-XA-ANTIDOT

SPC Number:

Dates

Filing date:

24/02/2017

Grant date:

02/06/2021

EP Publication Date:

02/01/2019

PCT Publication Date:

31/08/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/06/2021

EP B1 Publication Date:

02/06/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/02/2022

Expiration date:

24/02/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/05/2021

 

 

Name:

Alexion Pharmaceuticals, Inc.

Address:

121 Seaport Boulevard, Boston, MA 02210, United States (US)

Inventor

Name:

NGUYEN, Phuong M.

Address:

United States (US)

Priority

Priority Number:

201662299369 P

Priority Date:

24/02/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/36; A61K 38/48; A61K 9/19; C07K 14/00; A61K 9/00; A61P 9/00; A61P 39/02; A61P 7/00; A61K 47/18; A61K 47/26; C12N 9/64;

Publication

European Patent Bulletin

Issue number:

202122

Publication date:

02/06/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages